BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 16871529)

  • 1. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
    Zhou X; Tan FK; Guo X; Arnett FC
    Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation.
    Zhou XD; Xiong MM; Tan FK; Guo XJ; Arnett FC
    Arthritis Rheum; 2006 Dec; 54(12):3885-9. PubMed ID: 17133596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
    Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
    Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
    Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
    Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of expression of extracellular matrix genes with siRNAs to Sparc and Ctgf in skin fibroblasts of CTGF transgenic mice.
    Wang JC; Sonnylal S; Arnett FC; De Crombrugghe B; Zhou X
    Int J Immunopathol Pharmacol; 2011; 24(3):595-601. PubMed ID: 21978691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.
    Wang JC; Lai S; Guo X; Zhang X; de Crombrugghe B; Sonnylal S; Arnett FC; Zhou X
    Arthritis Res Ther; 2010; 12(2):R60. PubMed ID: 20359365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
    Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
    J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
    Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
    Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
    Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
    Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts.
    Gore-Hyer E; Pannu J; Smith EA; Grotendorst G; Trojanowska M
    Arthritis Rheum; 2003 Mar; 48(3):798-806. PubMed ID: 12632435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
    Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
    Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Cis-retinoic acid exhibits antifibrotic activity via the induction of cyclooxygenase-2 expression and prostaglandin E2 production in scleroderma fibroblasts.
    Xiao R; Kanekura T; Yoshida N; Higashi Y; Yan KL; Fukushige T; Kanzaki T
    Clin Exp Dermatol; 2008 Jul; 33(4):484-90. PubMed ID: 18462443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1.
    Holmes A; Abraham DJ; Chen Y; Denton C; Shi-wen X; Black CM; Leask A
    J Biol Chem; 2003 Oct; 278(43):41728-33. PubMed ID: 12888575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts.
    Wang JF; Olson ME; Ma L; Brigstock DR; Hart DA
    Wound Repair Regen; 2004; 12(2):205-16. PubMed ID: 15086772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.